Physician Assistant in Spencer, IA Accepting Medicare
6 Physician Assistant nurses found. Showing 1 - 6
 Rachele Randall, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E Ste C, Spencer, IA 51301 Phone: 712-262-7511 Fax: 712-262-3658 |
Carol Ann Olberding, P.A. - C Physician Assistant Medicare: Medicare Enrolled Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 |
Mrs. Jody Marie Vulk, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1200 1st Ave E, Ste C, Spencer, IA 51301 Phone: 712-262-7511 Fax: 712-262-3658 |
Briana Wetrich, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3525 |
 James Alfred Reser, P.A. - C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 |
Edwin Francisco Suaza, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St Ste 101, Spencer, IA 51301 Phone: 712-264-3500 |
News Archive
New survey on the U.S. market for synthetic oligonucleotides
According to a recent survey, the overwhelming majority (91%) of scientific customers have not changed their primary supplier of custom synthetic oligonucleotides (oligos) over the past 12 months.
Study demonstrates superiority of AE technique for ACL reconstruction in children
A new study demonstrates the superiority of a specific technique to perform anterior cruciate ligament (ACL) reconstruction in children. In recent years, the number of ACL surgeries in pediatric athletes has skyrocketed.
Calistoga Pharmaceuticals to present data on its CAL-101 inhibitor at the 51st ASH meeting
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced that clinical and preclinical data supporting the role of CAL-101, an oral, p110δ(delta) selective PI3K inhibitor in patients with hematologic malignancies, will be featured in two oral presentations at the upcoming 51st American Society of Hematology (ASH) Annual Meeting taking place in New Orleans, LA.
A revolutionary approach transforms bone trauma treatment
In the late 1950s, the treatment for fractures involved three to four months in hospital in plaster-casts and traction. Recovery was slow, and up to 70 percent of patients experienced reduced mobility upon recovery.
Eating lots of vegetables reduces risk of prostate cancer
In the online edition of Molecular Nutrition and Food Research, Ruth Chan and collaborators provided a review on prostate cancer (CaP) and vegetable consumption.
› Verified 7 days ago
Nurse Practitioner
Nurse Anesthetist - CR
Physician Assistant
Registered Nurse